Drugs / Detox-B adjuvant
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002767 | Jan 1996 → ? | cutaneous melanoma | GlaxoSmithKline | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Detox-B adjuvant | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002767 ↗ |
| Route | Subcutaneous | “allogenic melanoma cell lysate vaccine with detoxified endotoxin subcutaneously (SQ)” NCT00002767 ↗ |